Filing Details
- Accession Number:
- 0001209191-23-042229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-13 16:56:59
- Reporting Period:
- 2023-07-11
- Accepted Time:
- 2023-07-13 16:56:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746298 | Scott Richard Struthers | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-07-11 | 24,384 | $20.14 | 656,421 | No | 4 | S | Indirect | By Family Trust 1 |
| Common Stock | Disposition | 2023-07-12 | 11,459 | $20.17 | 644,962 | No | 4 | S | Indirect | By Family Trust 1 |
| Common Stock | Disposition | 2023-07-13 | 14,157 | $20.35 | 630,805 | No | 4 | S | Indirect | By Family Trust 1 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Family Trust 1 |
| No | 4 | S | Indirect | By Family Trust 1 |
| No | 4 | S | Indirect | By Family Trust 1 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 125,522 | Direct | |
| Common Stock | 1,000 | Indirect | By Spouse |
| Common Stock | 90,000 | Indirect | By Family Trust 2 |
| Common Stock | 90,000 | Indirect | By Family Trust 3 |
| Common Stock | 90,000 | Indirect | By Family Trust 4 |
Footnotes
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.14 per share. The range of sales prices on the transaction date was $20.10 to $20.25 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.17 per share. The range of sales prices on the transaction date was $20.10 to $20.31 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.35 per share. The range of sales prices on the transaction date was $20.10 to $20.68 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Billionaire Hedge Funds
